CF patients using Kaftrio/Trikafta may enjoy ‘near normal’ lifespans
A simulation study supported by Vertex reported that CF patients using Kaftrio (Trikafta in US) might live to a median age of 71.6.
0 Comments
CF patients using Kaftrio/Trikafta may enjoy ‘near normal’ lifespans
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed